OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
Condition(s):Geographic Atrophy; Age-Related Macular Degeneration; AMDLast Updated:July 14, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Geographic Atrophy; Age-Related Macular Degeneration; AMDLast Updated:July 14, 2020Completed
Condition(s):Age-Related Macular Degeneration; Geographic AtrophyLast Updated:July 7, 2021Completed
Condition(s):Age-Related Macular DegenerationLast Updated:July 14, 2020Completed
Condition(s):Geographic AtrophyLast Updated:January 20, 2014Terminated
Condition(s):Age-Related Macular DegenerationLast Updated:May 29, 2015Terminated
Condition(s):Age-Related Macular DegenerationLast Updated:March 26, 2024Active, not recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:June 2, 2016Terminated
Condition(s):Age-related Macular Degeneration; Geographic AtrophyLast Updated:February 26, 2015Unknown status
Condition(s):Geographic AtrophyLast Updated:February 21, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.